As of March 31, 2023, the Company held cash and cash equivalents of $27.7 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on REUN:
- Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
- Reunion Neuroscience Explodes Higher on Buyout Deal
- Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact
- Reunion Neuroscience initiated with a Buy at ThinkEquity
